159 related articles for article (PubMed ID: 35063619)
1. Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro.
Li X; Wang C; Chen J; Hu X; Zhang H; Li Z; Lan B; Zhang W; Su Y; Zhang C
Toxicol Lett; 2022 Apr; 358():40-47. PubMed ID: 35063619
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
[TBL] [Abstract][Full Text] [Related]
3. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
4. Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids.
Singh R; Wu B; Tang L; Hu M
J Agric Food Chem; 2011 Jul; 59(13):7452-64. PubMed ID: 21413806
[TBL] [Abstract][Full Text] [Related]
5. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.
Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L
Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958
[TBL] [Abstract][Full Text] [Related]
6. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
7. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3).
Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ
Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550
[TBL] [Abstract][Full Text] [Related]
9. Human UDP-Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol.
Zhu L; Xiao L; Li W; Zhang Y; Han W; Zhu Y; Ge G; Yang L
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):505-511. PubMed ID: 27176228
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions.
Wang Z; Wang X; Wang Z; Jia Y; Feng Y; Jiang L; Xia Y; Cao J; Liu Y
Toxicol Lett; 2021 Sep; 348():10-17. PubMed ID: 34044055
[TBL] [Abstract][Full Text] [Related]
11. Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro.
Chen J; Zhang H; Hu X; Xu M; Su Y; Zhang C; Yue Y; Zhang X; Wang X; Cui W; Zhao Z; Li X
Toxicol In Vitro; 2022 Oct; 84():105447. PubMed ID: 35868516
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
Korprasertthaworn P; Chau N; Nair PC; Rowland A; Miners JO
Biochem Pharmacol; 2019 Nov; 169():113616. PubMed ID: 31445021
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of opicapone on activity of human UDP-glucuronosyltransferases isoforms.
Wang Z; Wang Z; Wang X; Lv X; Yin H; Fan X; Yan M; Jia Y; Jiang L; Xia Y; Li W; Liu Y
Toxicol Lett; 2022 Aug; 367():3-8. PubMed ID: 35810997
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the metabolic activity, isozyme contribution, species differences and potential drug-drug interactions of PI-103, and the identification of efflux transporters for PI-103-
Gao L; Qin Z; Zhang B; Yin Z; Zhang X; Yang J
RSC Adv; 2020 Mar; 10(16):9610-9622. PubMed ID: 35497201
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Accurate Composition and Total Abundance of Homologous Proteins by Conserved-Plus-Surrogate Peptide Approach: Quantification of UDP Glucuronosyltransferases in Human Tissues.
Ahire D; Patel M; Deshmukh SV; Prasad B
Drug Metab Dispos; 2023 Mar; 51(3):285-292. PubMed ID: 36446609
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Chem Biol Interact; 2023 Aug; 381():110574. PubMed ID: 37263554
[TBL] [Abstract][Full Text] [Related]
19. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
20. Piceatannol exhibits potential food-drug interactions through the inhibition of human UDP-glucuronosyltransferase (UGT) in Vitro.
Jiang L; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol In Vitro; 2020 Sep; 67():104890. PubMed ID: 32446839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
